Overview
Harumitsu Suzuki practices practicing medicine in Wakayama, Japan.
Their clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), CACH Syndrome, and Calcinosis.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Harumitsu Suzuki
Is Harumitsu Suzuki a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Harumitsu Suzuki is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Harumitsu Suzuki participate in research or clinical trials?
Yes. Harumitsu Suzuki has published 14 articles and abstracts on conditions like COVID-19. You can view a list of Harumitsu Suzuki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CACH SyndromeSuzuki isExperienced. Learn about CACH Syndrome.
- CalcinosisSuzuki isExperienced. Learn about Calcinosis.
- COVID-19Suzuki isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)